GELSTAT CORP

GELSTAT CORP develops, manufactures, and markets over-the-counter (OTC) and other non-prescription consumer health products. The company was incorporated on November 13, 1991, in Minnesota as Developed Technology Resource, Inc., and reincorporated in Delaware on October 27, 2010. Its principal executive office is located at 3557 SW Corporate Parkway Palm City, FL. Effective April 30, 2003, GELSTAT CORP acquired Gelstat Corp. ("GC") as a wholly-owned subsidiary. GC, organized in June 2002, focuses on products related to migraine and sleep. The acquisition involved a merger where GC became a wholly-owned subsidiary, and its former owners received shares of GELSTAT CORP common stock, with no cash consideration exchanged. In July 2003, the company changed its name to Gelstat Corporation. On March 17, 2004, GS Corp. was merged into its parent company, Gelstat Corporation. In 2004, GELSTAT CORP established a subsidiary named GS Pharma, Inc. On January 5, 2005, GS Pharma assigned all rights in a license previously granted to it by Gelstat to DTLL, Inc. (OTCBB: DTLI) in exchange for 12.5 million shares of DTLL. On November 14, 2005, GELSTAT CORP sold 12.4 million of its DTLL shares for $500,000. Due to DTLL's failure to make required payments for pharmaceutical application rights, these rights reverted back to GELSTAT CORP. In late 2005, the company became insolvent and marketed its products on a limited basis.